|
HCFC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.9360000269586E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.53049994478761E-09 |
| Normal-vs-Stage2 |
2.219800E-04 |
| Normal-vs-Stage3 |
4.599000E-04 |
| Normal-vs-Stage4 |
1.584600E-01 |
| Stage1-vs-Stage2 |
9.835000E-01 |
| Stage1-vs-Stage3 |
6.209000E-01 |
| Stage1-vs-Stage4 |
8.909400E-01 |
| Stage2-vs-Stage3 |
6.507200E-01 |
| Stage2-vs-Stage4 |
9.289200E-01 |
| Stage3-vs-Stage4 |
9.075000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.09910036206441E-10 |
| Normal-vs-AfricanAmerican |
3.445600E-04 |
| Normal-vs-Asian |
2.604600E-03 |
| Caucasian-vs-AfricanAmerican |
3.185800E-01 |
| Caucasian-vs-Asian |
9.856800E-01 |
| AfricanAmerican-vs-Asian |
7.468800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.16410001030454E-10 |
| Normal-vs-Female |
1.199350E-03 |
| Male-vs-Female |
4.041900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.220810E-04 |
| Normal-vs-Extreme_Weight |
2.6257995777712E-10 |
| Normal-vs-Obese |
1.257880E-03 |
| Normal-vs-Extreme_Obese |
1.578320E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.098000E-01 |
| Normal_Weight-vs-Obese |
2.772400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.866000E-01 |
| Extreme_Weight-vs-Obese |
2.233700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.398000E-01 |
| Obese-vs-Extreme_Obese |
4.146600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.552000E-02 |
| Normal-vs-Age(41-60Yrs) |
4.1705000000003E-05 |
| Normal-vs-Age(61-80Yrs) |
1.02070019103451E-10 |
| Normal-vs-Age(81-100Yrs) |
4.616300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.799800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.152570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.904000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.071900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.839040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.234800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.71370029278251E-10 |
| Normal-VS-Type2 PRCC |
1.9081399999954E-05 |
| Normal-VS-KIRP CIMP |
8.306400E-02 |
| Normal-VS-Unclassified PRCC |
1.139590E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.453800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.582200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.046170E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.941400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.953170E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.186800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.88420000105205E-08 |
| Normal-vs-N1 |
4.017600E-02 |
| Normal-vs-N2 |
1.210740E-04 |
| N0-vs-N1 |
1.667840E-01 |
| N0-vs-N2 |
6.475800E-01 |
| N1-vs-N2 |
3.814200E-01 |
|
|
